公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2019 | Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population | CHING-HUNG LIN ; Yap Y.S.; Lee K.-H.; Im S.-A.; Naito Y.; Yeo W.; Ueno T.; Kwong A.; Li H.; Huang S.-M.; Leung R.; Han W.; Tan B.; Hu F.-C.; CHIUN-SHENG HUANG ; ANN-LII CHENG ; YEN-SHEN LU ; Asian Breast Cancer Cooperative Group | Journal of the National Cancer Institute | 81 | 73 | |
2013 | CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer | SUNG-HSIN KUO ; Yang, Shi-Yi; HUANG-CHUN LIEN ; Chiao Lo ; CHING-HUNG LIN ; YEN-SHEN LU ; ANN-LII CHENG ; KING-JEN CHANG ; CHIUN-SHENG HUANG | BioMed Research International | 9 | 9 | |
2008 | The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers | CHIUN-SHENG HUANG ; SUNG-HSIN KUO ; HUANG-CHUN LIEN ; Yang S.-Y.; You S.-L.; Shen C.-Y.; CHING-HUNG LIN ; YEN-SHEN LU ; KING-JEN CHANG | Oncologist | 19 | 18 | |
2023 | Deep-learning based breast cancer detection for cross-staining histopathology images | Huang, Pei-Wen; Ouyang, Hsu; Hsu, Bang-Yi; Chang, Yu-Ruei; Lin, Yu-Chieh; Chen, Yung-An; Hsieh, Yu-Han; Fu, Chien-Chung; Li, Chien-Feng; CHING-HUNG LIN ; Lin, Yen-Yin; Dah-Tsyr Chang, Margaret; Pai, Tun-Wen | Heliyon | 3 | 2 | |
2018 | Development of a general method for quantifying IgG-based therapeutic monoclonal antibodies in human plasma using protein G purification coupled with a two internal standard calibration strategy using LC-MS/MS | Chiu, Huai Hsuan; Liao, Hsiao Wei; YU-YUN SHAO ; YEN-SHEN LU ; CHING-HUNG LIN ; Tsai, I. Lin; CHING-HUA KUO | Analytica Chimica Acta | 47 | 45 | |
2017 | Development of a Postcolumn Infused-Internal Standard Liquid Chromatography Mass Spectrometry Method for Quantitative Metabolomics Studies | Liao H.-W.; GUAN-YUAN CHEN ; MING-SHIANG WU ; WEI-CHIH LIAO ; CHING-HUNG LIN ; CHING-HUA KUO | Journal of Proteome Research | 12 | 10 | |
2022 | Development of an efficient mAb quantification assay by LC-MS/MS using rapid on-bead digestion | Chiu, Huai-Hsuan; Tsai, Yun-Jung; Chiao Lo ; CHING-HUNG LIN ; Tsai, I-Lin; CHING-HUA KUO | Analytica Chimica Acta | 5 | 5 | |
2022 | Development of an LC-MS/MS method to simultaneously quantify therapeutic mAbs and estimate hematocrit values in dried blood spot samples | Chiu, Huai-Hsuan; Tsai, Yun-Jung; Chiao Lo ; Liao, Hsiao-Wei; CHING-HUNG LIN ; SUNG-CHUN TANG ; CHING-HUA KUO | Analytica Chimica Acta | 5 | 5 | |
2017 | Development of an LC-MS/MS method with protein G purification strategy for quantifying bevacizumab in human plasma | Chiu H.-H.; Tsai I.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; CHING-HUA KUO | Analytical and Bioanalytical Chemistry | 20 | 15 | |
2011 | Dielectrophoresis-based cellular microarray chip for anticancer drug screening in perfusion microenvironments | Hsiung, L.-C.; Chiang, C.-L.; Wang, C.-H.; Huang, Y.-H.; Kuo, C.-T.; Cheng, J.-Y.; CHING-HUNG LIN ; Wu, V.; Chou, H.-Y.; Jong, D.-S.; Lee, H.; ANDREW WO | Lab on a Chip | 50 | 45 | |
2014 | Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Lee Y.-H.; YUNG-MING JENG ; CHING-HUNG LIN ; YEN-SHEN LU ; Yao Y.-T. | Histopathology | 33 | 28 | |
2013 | Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance | HUANG-CHUN LIEN ; Wang C.-C.; CHING-HUNG LIN ; YEN-SHEN LU ; CHIUN-SHENG HUANG ; Hsiao L.-P.; Yao Y.-T. | Human Pathology | 12 | 12 | |
2023 | Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis | Peng, Shang-Hsuan; CHING-HUNG LIN ; I-CHUN CHEN ; YING-CHUN SHEN ; DWANG-YING CHANG ; WEI-WU CHEN ; Huang, Shu-Min; Hu, Fu-Chang; YEN-SHEN LU | Cancer medicine | 0 | 0 | |
2020 | Disparity in Tumor Immune Microenvironment of Breast Cancer and Prognostic Impact: Asian Versus Western Populations | Chen C.-H.; YEN-SHEN LU ; ANN-LII CHENG ; CHIUN-SHENG HUANG ; WEN-HUNG KUO ; Wang M.-Y.; Chao M.; I-CHUN CHEN ; Kuo C.-W.; TZU-PIN LU ; CHING-HUNG LIN | Oncologist | 31 | 32 | |
2013 | Distant metastasis in triple-negative breast cancer | Tseng L.M.; Hsu N.C.; Chen S.C.; YEN-SHEN LU ; CHING-HUNG LIN ; DWANG-YING CHANG ; Li H.; Lin Y.C.; Chang H.K.; Chao T.C.; Ouyang F.; Hou M.F. | Neoplasma | 93 | 85 | |
2014 | Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study | CHING-HUNG LIN ; Chuang P.-Y.; CHUN-JU CHIANG ; YEN-SHEN LU ; ANN-LII CHENG ; WEN-HUNG KUO ; CHIUN-SHENG HUANG ; Lai M.-S.; You S.-L.; Tang C.-H. | Oncologist | 39 | 39 | |
2016 | DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys | Chang, Yu-Ting; Yang, Ching-Chin; SZU-YU PAN ; YU-HSIANG CHOU ; FAN-CHI CHANG ; CHUN-FU LAI ; Tsai, Ming-Hsuan; Hsu, Huan-Lun; CHING-HUNG LIN ; WEN-CHIH CHIANG ; MING-SHIOU WU ; TZONG-SHINN CHU ; YUNG-MING CHEN ; SHUEI-LIONG LIN | The Journal of clinical investigation | 64 | 59 | |
2008 | Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients | SUNG-HSIN KUO ; HUANG-CHUN LIEN ; You S.-L.; YEN-SHEN LU ; CHING-HUNG LIN ; Chen T.-Z.; CHIUN-SHENG HUANG | Breast | 12 | 12 | |
2006 | Downregulation of BRG-1 repressed expression of CD44s in cervical neuroendocrine carcinoma and adenocarcinoma | KUAN-TING KUO ; Liang C.-W.; Hsiao C.-H.; CHING-HUNG LIN ; CHI-AN CHEN ; BOR-CHING SHEU ; Lin M.-C. | Modern Pathology | 18 | 16 | |
2012 | Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy | Kuo Y.-H.; CHING-HUNG LIN ; Shau W.-Y.; Chen T.-J.; SHIH-HUNG YANG ; Huang S.-M.; CHIUN HSU ; YEN-SHEN LU ; ANN-LII CHENG | BMC Cancer | 19 | 16 | |